Log In Sign up
The largest database of trusted experimental protocols

Ha antibody prb 101p

Manufactured by Fortrea
Visit Supplier

The HA antibody (PRB-101P) is a laboratory reagent designed for use in various research applications. It is a monoclonal antibody that specifically recognizes the hemagglutinin (HA) protein, which is commonly found on the surface of influenza viruses. The HA antibody can be used to detect and identify the presence of HA in samples, but its specific intended use should be determined by the researcher based on their experimental requirements.

Automatically generated - may contain errors

Lab products found in correlation

Rapamycin r0395, by Merck Group (2 mentions) β actin antibody a1978, by Merck Group (2 mentions) 03 gp62 c, by Santa Cruz Biotechnology (2 mentions) Sc 28359, by Santa Cruz Biotechnology (2 mentions) Hif2α antibody nb100 122, by Novus Biologicals (2 mentions) Atg7 antibody 8558, by Cell Signaling Technology (2 mentions) Beclin 1 antibody b6186, by Merck Group (2 mentions) Lamp1 antibody, by BD (2 mentions) Gfp antibody sc 8334, by Santa Cruz Biotechnology (2 mentions) P53 antibody sc 126, by Santa Cruz Biotechnology (2 mentions) Bafilomycin a1 b 1080, by LC Laboratories (2 mentions)

2 protocols using ha antibody prb 101p

1

Antibody Sources and Reagents for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC3B antibody was prepared by the Eissa laboratory as previously described (43 (link)). p62 antibody was from American Research Products, Inc (03-GP62-C) or Santa Cruz Biotechnology, Inc (sc-28359). HIF2α antibody (NB100-122) was from Novus Biologicals. VHL antibody (2738), S6 antibody (2117), P-S6 antibody (2211), beclin 1 antibody (3495), LDHA antibody (3558), Lamin A antibody (2032), ATG5 antibody (8540) and ATG7 antibody (8558) were from Cell Signaling Technology. ATG7 antibody (LS-B330) for immunohistochemistry was from LifeSpan Bioscences. Beclin 1 antibody (B6186) for immunohistochemistry, β-actin antibody (A1978) and rapamycin (R0395) were from Sigma. HA antibody (PRB-101P) was from Covance. LAMP1 antibody was form BD Biosciences Pharmingen (555798). GFP antibody (sc-8334) and p53 antibody (sc-126) were from Santa Cruz Biotechnology. Chromotek-GFP-Trap Resin Agarose (ACT-CM-GFA0050) was from Allele Biotechnology. Bafilomycin A1 (B-1080) was from LC Laboratories. MG132 (474790) was from Calbiochem.
Liu X.D., Yao J., Tripathi D.N., Ding Z., Xu Y., Sun M., Zhang J., Bai S., German P., Hoang A., Zhou L., Jonasch D., Zhang X., Conti C.J., Efstathiou E., Tannir N.M., Eissa N.T., Mills G.B., Walker C.L, & Jonasch E. (2014). Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis. Oncogene, 34(19), 2450-2460.
+ Open protocol
+ Expand
2

Antibody Sources and Reagents for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC3B antibody was prepared by the Eissa laboratory as previously described (43 (link)). p62 antibody was from American Research Products, Inc (03-GP62-C) or Santa Cruz Biotechnology, Inc (sc-28359). HIF2α antibody (NB100-122) was from Novus Biologicals. VHL antibody (2738), S6 antibody (2117), P-S6 antibody (2211), beclin 1 antibody (3495), LDHA antibody (3558), Lamin A antibody (2032), ATG5 antibody (8540) and ATG7 antibody (8558) were from Cell Signaling Technology. ATG7 antibody (LS-B330) for immunohistochemistry was from LifeSpan Bioscences. Beclin 1 antibody (B6186) for immunohistochemistry, β-actin antibody (A1978) and rapamycin (R0395) were from Sigma. HA antibody (PRB-101P) was from Covance. LAMP1 antibody was form BD Biosciences Pharmingen (555798). GFP antibody (sc-8334) and p53 antibody (sc-126) were from Santa Cruz Biotechnology. Chromotek-GFP-Trap Resin Agarose (ACT-CM-GFA0050) was from Allele Biotechnology. Bafilomycin A1 (B-1080) was from LC Laboratories. MG132 (474790) was from Calbiochem.
Liu X.D., Yao J., Tripathi D.N., Ding Z., Xu Y., Sun M., Zhang J., Bai S., German P., Hoang A., Zhou L., Jonasch D., Zhang X., Conti C.J., Efstathiou E., Tannir N.M., Eissa N.T., Mills G.B., Walker C.L, & Jonasch E. (2014). Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis. Oncogene, 34(19), 2450-2460.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!